The Technical Network for Strengthening Immunization Services

We are a global network of immunization professionals committed to strengthening immunization services by building relationships, sharing knowledge, coordinating activities, and aligning priorities and goals. Learn More.

Already a member? Log in
  Friday, 11 March 2016
  2 Replies
  9.3K Visits

From today's Guardian

Health workers face suspicion and a lack of cold storage as they test the Ebola vaccine

http://www.theguardian.com/global-development/2016/mar/10/ebola-vaccine-trial-sierra-leone-fear-logistics-immunisations

Dr Tamba Manye, who works for the World Health Organisation (WHO) in Tonkolili, says logistics need to be improved before the unlicensed vaccine can be made more widely available.“There is no cold chain facility in Sierra Leone that can deal with the vaccine because it has to be stored at minus 80 degrees celcius. The only facility is in Guinea, so we had to fly the vaccines from there.

8 years ago
·
#4006

Hi Patrick

This really makes me wonder.

I was there in 2013 with T.O from WHO/HQ and T.O from Unicef SD to do the planning of the introduction of a -80C cold chain. Everything was panned to detail, as far as I know the equipment was also ordered, also forTonkolili.

Does anybody know what happened or not happened.

best

soren

8 years ago
·
#4008

Hi Patrick,

The British medical journal The Lancet reported the clinical trial results of an experimentalEbolavaccine tested last year in the West African nation of Guineaduring the continuingoutbreak of the viral diseasethat had shown promising initial results.

The clinical trial included the use of a beer-keg-shaped vaccine storage device, the Arktek. It allowed the vaccines to be transported and kept at minus 80 degrees in outlying areas without electricity for many days, which was deemed necessary because the vaccine’s stability at higher temperatures had not yet been fully tested. The storage device was invented by Global Good, and developed/manufactured by Aucma in China.

The New York Times published the story on July 15, 2015. Here is the link: http://www.nytimes.com/2015/08/01/world/africa/experimental-ebola-vaccine-in-guinea-shows-promise-report-says.html?register=google&_r=2

Anyone who wants to know more about the Arktek product should visit website www.arktek.org, or www.globalgood.com. They can also email [email protected] for more information.

Best regards,

Zihong Guo

  • Page :
  • 1
There are no replies made for this post yet.

Our community, our knowledge

6137 members

TechNet members are immunization professionals working to improve immunization services in every country and at all levels from global policy formulation and national programme management all the way to service delivery at subnational levels.

  • Connect with each other and make new contacts
  • Ask questions, provide answers, and share knowledge in our forum
  • Join specialist groups (communities of practice)
  • Track upcoming events, such as webinars, training opportunities and global events
  • Browse key publications on Hot Topics curated by global experts
  • Search for guidance in our Knowledge Hub
wood croud background

Our Partners

We are proud to work with many organizations and initiatives across the world in our efforts to help strengthen immunization services. We support the work of all immunization professionals, from both the public and private sector, from governments and international organizations to NGOs, academic institutions, companies and manufacturers. TechNet is a member of two global immunization partnerships:

Gavi Alliance’s immunization Supply Chain Steering Committee (iSC2)

Bill and Melinda Gates Logo
Clinton logo
GAVI logo
GAVI logo
JSI logo
PATH logo
UNICEF logo
USAID logo
Village Reach logo
WHO logo

Partnership of Immunization Networks

Boost logo
IAPHL logo
IA Watch logo
Geneva Learning Foundation logo